A detailed history of Gratus Wealth Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Gratus Wealth Advisors, LLC holds 3,693 shares of NVO stock, worth $388,762. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,693
Previous 2,185 69.02%
Holding current value
$388,762
Previous $287 Million 51.32%
% of portfolio
0.07%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$119.07 - $145.42 $179,557 - $219,293
1,508 Added 69.02%
3,693 $435 Million
Q2 2024

Jul 22, 2024

BUY
$122.71 - $146.91 $57,182 - $68,460
466 Added 27.11%
2,185 $287 Million
Q1 2024

May 09, 2024

BUY
$102.11 - $135.92 $175,527 - $233,646
1,719 New
1,719 $211 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Gratus Wealth Advisors, LLC Portfolio

Follow Gratus Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratus Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratus Wealth Advisors, LLC with notifications on news.